References
- Breyer F. Reimbursement and cost containment. A German perspective. Pharmacoeconomics 20(Suppl. 3), 87–94 (2002).
- Roger EM. Diffusion of Innovations. The Free Press, NY, USA (1995).
- Wörz M, Perleth M, Schöffski O, Schwartz FW. Innovative Medizinprodukte im. deutschen Gesundheitswesen. Nomos, Germany (2002).
- Ramsey SD, Luce BR, Deyo R, Franklin G. The limited state of technology assessment for medical devices: facing the issues. Am. J. Managed Care 4, 188–199 (1998).
- Glynn D. Reimbursement for new health technologies. Pharmacoeconomics 18(Suppl. 1), 59–67 (2000).
- Altenstetter C. EU Regulation of the Medical Device Industry and Medical Goods and Equipment. International Political Science Association, Quebec, Canada (2000).
- Hodgson J, Bottner RK, Klein LW et al. Drug-Eluting Stent Task Force. Final report and recommendations of the working committees on cost–effectiveness/economics, access to care, and medicolegal issues. Cathet. Cardiovasc. Interventions 62, 1–17 (2004).
- Hessel FP, Wegner C, Müller J, Glaveris C, Wasem J. Economic evaluation and survival analysis of immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy Eur. J. Health Econ. 5, 58–63 (2003).
- Weinmann J, Zifonun N. Gesundheitsausgaben und Gesundheitspersonal 2001. Statistisches Bundesamt – Wirtschaft und Statistik 6, 519–530 (2003).
- Neubauer G, Lindl C, Knappe E, Zimmermann T, Seeger T, Sullivan K. Die Bedeutung von Medizinprodukten im. Deutschen Gesundheitswesen. BVMed, Germany (2000).
- Neubauer G. The hospital care system in germany. BKK 8, 394–399 (2003).
- Leister JE, Stausberg J. Comparison of cost accounting methods from different DRG systems and their effect on healthcare quality. Health Policy (2005) (In Press).
- Greß S, Niebuhr D, Rothgang H, Wasem J. Criteria and procedures for determining benefit packages in healthcare: a comparative perspective. Health Policy (2005) (In Press).
- Black N. Why we need observational studies to evaluate the effectiveness of healthcare. Br. Med. J. 312 (7040), 1215–1218 (1996).
- Mowatt G, Bower DJ, Brebner JA et al. When is the ‘right’ time to initiate an assessment of a health technology. Int. J. Technol. Assess. Health 14(2), 372–286 (1998).
- Neubauer G, Ulyaki R. Bedeutung von Innovationen für die Medizinprodukteindustrie. In: Zukunftsorientiertes Management in der Medizinprodukteindustrie. Oberender PO, Schommer R, Da-Cruz P (Eds). Verlag PCO, Germany, 149–161 (2004).
Websites
- Homepage of the German Hospital Association (Deutsche Krankenhausgesellschaft DKG) www.dkgev.de (Accessed July 2005)
- Catalog of additional payments www.g-drg.de/service/download/veroeff_2005/Endfassung_FallpauschalenKatalog_A4_A6_050103.xls (Accessed July 2005)
- INEK homepage www.g-drg.de (Accessed July 2005)
- GemBA homepage www.g-ba.de (Accessed July 2005)